Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Reddin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Methods in Molecular Medicine|February 22, 2011
Animal models for meningococcal diseaseA R Gorringe, K M Reddin, P Voet, et al.
Contributions to Microbiology and Immunology|January 1, 1995
Large-scale purification of the F1 antigen of Yersinia pestisK M Reddin, T J Easterbrook, A Robinson, et al.
Infection and Immunity|November 24, 1999
Human opsonins induced during meningococcal disease recognize transferrin binding protein complexesA K Lehmann, A R Gorringe, K M Reddin, et al.
Vaccine|March 10, 2005
Experimental disease models for the assessment of meningococcal vaccinesA R Gorringe, K M Reddin, S G Funnell, et al.
FEMS Immunology and Medical Microbiology|September 11, 2001
Bordetella pertussis fimbriae are effective carrier proteins in Neisseria meningitidis serogroup C conjugate vaccinesK M Reddin, A Crowley-Luke, S O Clark, et al.
Infection and Immunity|January 10, 1998
Periplasmic superoxide dismutase in meningococcal pathogenicityK E Wilks, K L Dunn, J L Farrant, et al.
Vaccine|June 17, 1998
Comparison of the immunological and protective responses elicited by microencapsulated formulations of the F1 antigen from Yersinia pestisK M Reddin, T J Easterbrook, S M Eley, et al.
FEMS Immunology and Medical Microbiology|December 1, 1995
A new improved sub-unit vaccine for plague: the basis of protectionE D Williamson, S M Eley, K F Griffin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Methods in Molecular Medicine|February 22, 2011
Animal models for meningococcal diseaseA R Gorringe, K M Reddin, P Voet, et al.
Contributions to Microbiology and Immunology|January 1, 1995
Large-scale purification of the F1 antigen of Yersinia pestisK M Reddin, T J Easterbrook, A Robinson, et al.
Infection and Immunity|November 24, 1999
Human opsonins induced during meningococcal disease recognize transferrin binding protein complexesA K Lehmann, A R Gorringe, K M Reddin, et al.
Vaccine|March 10, 2005
Experimental disease models for the assessment of meningococcal vaccinesA R Gorringe, K M Reddin, S G Funnell, et al.
FEMS Immunology and Medical Microbiology|September 11, 2001
Bordetella pertussis fimbriae are effective carrier proteins in Neisseria meningitidis serogroup C conjugate vaccinesK M Reddin, A Crowley-Luke, S O Clark, et al.
Infection and Immunity|January 10, 1998
Periplasmic superoxide dismutase in meningococcal pathogenicityK E Wilks, K L Dunn, J L Farrant, et al.
Vaccine|June 17, 1998
Comparison of the immunological and protective responses elicited by microencapsulated formulations of the F1 antigen from Yersinia pestisK M Reddin, T J Easterbrook, S M Eley, et al.
FEMS Immunology and Medical Microbiology|December 1, 1995
A new improved sub-unit vaccine for plague: the basis of protectionE D Williamson, S M Eley, K F Griffin, et al.
Pageof 1